Remove Arcturus Remove Capital Remove Funding Remove San Diego
article thumbnail

Arcturus Therapeutics Gets $220M More In Support For Vaccine Efforts

socalTECH

San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds. READ MORE>>.

Arcturus 113
article thumbnail

Arcturus Therapeutics Gets $5M

socalTECH

San Diego-based Arcturus Therapeutics , a developer of RNAi technology, said it has raised $5M in a Series A funding round. According to Arcturus, the funding came from multiple private capital,, high net worth investors from Canada, Japan, and the United States. READ MORE>>.

Arcturus 153
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sorrento Therapeutics Gets $2.3M

socalTECH

San Diego-based Sorrento Therapeutics , a new biotechnology startup, has raised $2.3M in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom.

Arcturus 100
article thumbnail

Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More

Xconomy

Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. It’s early yet in 2018, but the current count could put life-sciences companies on pace to bust past last year’s $17.6

Funding 52